Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Declines By 81.8%

Posted by Michael Walen on Dec 12th, 2024

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report) saw a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 200 shares, a decline of 81.8% from the November 15th total of 1,100 shares. Based on an average daily trading volume, of 3,100 shares, the short-interest ratio is presently 0.1 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

NASDAQ FTXH traded down $0.13 during mid-day trading on Wednesday, hitting $27.70. The company’s stock had a trading volume of 2,939 shares, compared to its average volume of 5,126. The stock’s fifty day simple moving average is $28.29 and its two-hundred day simple moving average is $28.21. First Trust Nasdaq Pharmaceuticals ETF has a 52-week low of $25.56 and a 52-week high of $29.72. The firm has a market capitalization of $16.62 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Thursday, September 26th were paid a dividend of $0.1218 per share. The ex-dividend date of this dividend was Thursday, September 26th. This represents a $0.49 dividend on an annualized basis and a yield of 1.76%.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

A hedge fund recently bought a new stake in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC bought a new position in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned about 0.41% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent SEC filing.

About First Trust Nasdaq Pharmaceuticals ETF

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.